The methods described herein for activation of naïve CD4 + T cells in suspension and their adherence in coverslips for confocal microscopy analysis allow the spatial localization and visualization of gangliosides involved in CD4 + T cell activation, that complement expression profiling experiments such as flow cytometry, western blotting or real-time PCR. The quantification of ganglioside expression through flow cytometry and their cellular localization through microscopy can be obtained by the use of anti-ganglioside antibodies with high affinity and specificity. Nonetheless, an adequate handling of cells in suspension involves the treatment of culture plates to promote the necessary adherence required for fluorescence or confocal microscopy acquisition. In this work, we describe a protocol for determining GD3 and GD2 ganglioside expression and colocalization with the TCR during naïve CD4 + T cell activation. Also, real-time PCR experiments using <40,000 cells are described for the determination of the GD3 and GM2/GD2 synthase genes, demonstrating that gene analysis experiments can be performed with a low number of cells and without the need of additional low input RNA kits.
Introduction
The CD4 + T cells orchestrate the immune response through their effector functions after activation by antigen presenting cells 1 . The study of the cellular mechanisms that are modulated during activation allows insight into a basic process of immune function. However, the study of naïve CD4 + T cells can be complicated because they represent a very small population of cells in the blood periphery 2 .
Through fluorescence microscopy several reports have studied the localization of different molecules involved in CD4 + T cell activation, mainly proteins associated to the plasma membrane 3 . The gangliosides are sialic acid containing glycosphingolipids and although they have been extensively studied in nerve cells where they are abundant, other cells such as immune cells also express gangliosides with biologically relevant functions 4, 5 . We previously reported that during activation of human naïve CD4 + T cells there is an upregulation of the α2,8 sialyltransferase ST8Sia 1 (GD3 synthase) and the GM2/GD2 synthase, that induce the significant surface neoexpression of GD2 and the upregulation of GD3 ganglioside 6 . Further study of GD3, GD2 and other gangliosides in immune cells is necessary to complement a protein-based partial view of immune function.
Commonly, the study of ganglioside expression is based on techniques such as Thin Layer Chromatography (TLC) 7 , but this technique does not allow the spatial localization of gangliosides at the plasma membrane or in subcellular compartments, limiting biological analysis.
In this work, we describe a protocol for the antibody-mediated identification and localization of GD3 and GD2 gangliosides in human naïve CD4+ T cells and PBMCs after anti-CD3/anti-CD28 activation. With this protocol it is also possible to analyze the gene and molecular expression of gangliosides in a low number of cells in suspension, with acquisition of high quality images
Isolation and Activation of Human Naïve CD4
+ T Cells 1. Collect 2 ml of peripheral blood derived from healthy human donors through informed consent and dilute with 2 ml of sterile PBS-EDTA (1x Phosphate Buffered Saline (PBS), 2 mM EDTA, pH 7.4). Add the diluted blood slowly on top of 3 ml of sucrose solution with 1.077 density as previously described 8 . Note: Differential migration during centrifugation caused by differences in density will cause erythrocytes to sediment completely and a layer of less dense mononuclear cells will form above. 2 ml of peripheral blood will render approximately 0.5 x 10 6 naïve CD4 + T cells after the purification steps. 2. Centrifuge 30 min at 250 x g at 21 °C (use rotor for round bottom tubes with fixed angle of 30 mm) with no break to generate the gradient of peripheral blood mononuclear cells (PBMCs). After centrifugation, the PBMCs can be clearly observed as a white ring. Collect the PBMCs with a pipette and transfer to sterile tube for washing. 3. After three washes with PBS-EDTA solution at 250 x g for 10 min proceed to the purification of naïve CD4 + T cells. Sorting methods or several types of purification kits are available for this purpose. Preferably, use >1 x 10 7 PBMCs for purification. ). 5. Remove the anti CD3 antibody dilution from the 24 well or 96 well plates and wash the plates twice using sterile 1x PBS. 6. Dilute the naïve CD4+ T cells with >95 % of purity (CD4+CD45RA+) to a density of 1 x 10 6 cells/ml in advanced RPMI 1640 medium supplemented with 3 % of fetal bovine serum (or RPMI supplemented with 10 % of serum), 2 mM glutamine and antibiotics (1 U/ml penicillin, 1 µg/ml streptomycin). Note: If ganglioside localization is required in PBMCs, follow the same protocol for dilution and stimulation as described below. 7. Add 500 µl of the cell dilution to anti CD3 coated wells and to non-coated wells (control cells) in the 24 well plate. Alternatively, add 100 µl of the cell dilution to the wells of the 96 well plate.
Complete the stimulation conditions of naïve CD4
+ T cells in anti CD3 coated wells by adding 1 µg/ml of anti CD28 antibody. 
Collecting and Fixation of Resting and Activated Naïve CD4
+ T Cells 1. Carefully remove the medium from cultured resting and activated naïve CD4 + T cells.
2. Add 500 µl of RT sterile PBS slowly. Note: Careful addition and removal of solutions from wells prevents the detachment of cells from the coverslip. 3. Discard the PBS and add another 500 µl PBS to thoroughly remove culture media. 4. Fix the cells by addition of 500 µl filtered 4% paraformaldehyde (filtration removes microparticles that can interfere with microscopy analysis) and incubate for 30 min at RT (preferred) or overnight at 4 °C. Caution: Paraformaldehyde is a toxic and volatile compound. It is known to be a human carcinogen. Use carefully with an appropriate safety protocol. 5. Remove the fixative and wash at least twice with PBS at RT. 6. Proceed to the next step or maintain the plate wells with 500 µl of PBS at 4 °C for several days until staining.
Note: Sterility during this process helps avoid microorganism growth.
2. Remove the blocking buffer carefully and add the primary antibodies (anti gangliosides GD3 clone R24, GD2 clone 14G2a), PE-conjugated anti CD25 and APC-conjugated anti TCR and isotypes controls diluted in blocking buffer to 2.5 µg/ml. 3. Incubate 2 hr on ice or overnight at 4 °C.
Note: Slow orbital agitation is preferable. 4. Remove the antibody carefully and add slowly 500 µl of PBS. Repeat twice. 5. Add the secondary antibodies (FITC conjugated anti IgG3 for R24 anti GD3, Alexa Fluor 488-conjugated or Alexa Fluor 647-conjugated anti IgG2a for 14G2a anti GD2) diluted in blocking buffer to 0.1 µg/ml. 6. Incubate for 1 hr on ice in the dark without shaking. 7. Wash three times in PBS as described in 4.4). Keep the wells with enough PBS to avoid the dehydration of samples. Note: Leaving the sample at -80 °C for at least 24 hr improves RNA yield. Also, use of hand gloves is essential to avoid RNA degradation by RNases. 6. Defrost the sample by incubation at 37 °C for 2 min in a water bath. 7. Add 200 µl chloroform and shake vigorously by hand for 30 sec (to avoid aggressive mixing of RNA by vortexing). Incubate 5 min at RT. 8. Centrifuge 15 min at 12,000 x g at 4 °C. 9. Recover the aqueous phase into a new microcentrifuge tube. 10. Add 500 µl isopropanol and invert the tube three times. 11. Incubate 10 min at RT and centrifuge for 10 min at 12,000 x g at 4 °C. 12. Discard the supernatant by inversion. 13. Add 1 ml of ice cold 75% ethanol and centrifuge 10 min at 12,000 x g at 4 °C. 14. Completely discard the supernatant and dry the RNA pellet by leaving the cap of the tube open.
Note: At this point the pellet is not clearly visible. Proceed anyway. 15. Resuspend the pellet in 20 µl of molecular grade water. Calculate the concentration and purity of nucleic acids by measuring the 260 nm and 280 nm absorbance using nanodrop. 16 . Proceed carefully to synthesis of cDNA by using any conventional reverse transcriptase kit and following the manufacturer´s protocol.
Note: Approximately 0.5-2 µg RNA is obtained from 4 x 10 4 naïve CD4 + T cells. cDNA can be synthetized from 100 ng of RNA and used in real-time PCR reactions without the need for low RNA input kits.
Representative Results
The protocol described in this manuscript renders a good quality of cultured and adhered resting and activated human naïve CD4 + T cells (Figure 1) . The activated CD4 + T cells show the characteristic proliferative profile ( Figure 1B ) in comparison to the resting condition ( Figure 1A) .
The CD25 late activation marker is useful to evaluate the efficient activation at 72 hr observed by confocal microscopy ( Figure 1C) . The CD69 marker is currently used as early activation marker by flow cytometry or microscopy. Adherence of resting and activated naïve CD4 + T cells to a coverslip coated with poly-L-lysine are useful to study the expression and localization of GD3 and TCR showed by a double labeling with anti GD3 and anti TCR antibodies (Figure 2) . As we reported previously, activation is accompanied by remodeling of GD3 and GD2 gangliosides in the cells surface 6 . Additionally, gene expression quantification of the GD3 and GM2/GD2 synthases is performed from 4 x 10 4 cells (Figures   2 and 3) . The neo-expression of the GD2 ganglioside and TCR colocalization is adequately observed by confocal microscopy, demonstrating a possible role of GD2 in TCR clustering during activation (Figure 3) . Figure 4 shows the localization of the GD3 and GD2 ganglioside stained simultaneously in activated CD4 + T cells. Additionally, activated PBMCs were stained with anti GD3 and anti GD2 antibodies showing that this protocol can be used in other immune cell populations found in PMBCs, particularly GD2 that was found to be expressed in all the activated PMBCs ( Figure 5 ). The GD3 and GD2 stain was assessed by confocal microscopy from one stack with a 60X S/1.3 oil objective with 2X digital zoom. Please click here to view a larger version of this figure. 
Discussion
The described protocol can be used to localize gangliosides or proteins in cell suspensions of CD4 + T cells or other immune cells (e.g. PMBCs, This protocol combined with a good quality confocal microscopy analysis is a key advantage over the use of techniques such as thin layer chromatography for detection of gangliosides because it reveals the spatial localization and dynamics of gangliosides during treatment (e.g. T cell activation), leading to acquisition of biologically relevant data 11, 12, 13 . Also, this protocol allows the evaluation of ganglioside expression starting from a small number of CD4 + T cells (2 x 10 4 ) that is useful for optimizing the number of replicates or different assays 6 .
The careful treatment during washes and antibody staining after adhesion is crucial to maintain cell number and integrity. Because of the weak binding of CD4 + T cells to the coverslip, it is also very important to carefully add and remove solutions; otherwise a reduction in cell number and increased fluorescent debris will be encountered. When assessed through confocal microscopy, the immunostaining of gangliosides confers additional information such as spatial localization or co-localization with other molecules in the plasma membrane or intracellular compartments. Subcellular localization requires the use of subcellular markers 14, 15 . In addition, fresh and not fixed CD4 + T cells need to be used for staining when determining ganglioside expression restricted to the cell surface. Although fixation of CD4 + T cells helps preserve the sample for at least 5 days, it carries the risk of permeabilization and intracellular staining.
However, because of the structural similarity between gangliosides, it is always advisable to take into account the specificity of antibodies used. Several of the commercially available anti-ganglioside monoclonal antibodies can be used and for some of them the specificity has been probed by ELISA, TLC, etc. 16, 17, 18 .
Previous works demonstrate that it is possible to obtain information regarding localization and expression of GD3 and GD2 gangliosides from 2 x 10 4 cells/per condition 6 . Also, this protocol describes the capability of performing gene profiling experiments from 4 x 10 4 cells, allowing optimization of silencing experiments such as those based in lentiviral particles 6 .
Disclosures
The authors have nothing to disclose.
